Management of Pleehodara Roga by Sharpunkha Kshara

A Clinico-Anatomical Study of Pleeha in Pleehodara Roga W.S.R. to Therapeutic Effect of Sharpunkha Kshara

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/08/027335

Enrollment

Registered

2020-08-24

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D731- Hypersplenism

Interventions

Intervention1: Sharpunkha Kshara: 1-3 grams for 30 days According to Patients Control Intervention1: Medicines Provides in OPD / IPD: Medicines use in Pleehodara Roga

Eligibility

Inclusion criteria

Inclusion criteria: Patients with the classical signs and symptoms of Pleehavridhi (splenomegaly).

Exclusion criteria

Exclusion criteria: Patients with other Systemic Diseases like Diabetes Mellitus, Malignancy, CHD, etc. HbsAg and HIV Positive Patients.

Design outcomes

Primary

Measure	Time frame
Improvement in Subjective and Objective criteria.Timepoint: 2 Weeks	—

Secondary

Measure	Time frame
To find out the Efficay of Sharpunkha KsharaTimepoint: 1 month	—

Countries

India

Contacts

Public ContactDr Rakesh Kumar Sharma

UNIVERSITY COLLEGE OF AYURVEDA JODHPUR

dranopsinghrathore@gmail.com9461452184

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026